|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0115 AUD | -4.17% |
|
-11.54% | -23.33% |
| 28/05 | Acrux licenses Lenzetto for Australian market for A$5.4 million | RE |
| 27/05 | Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia | RE |
| Market Cap | 6.16M 4.27M 3.74M 3.44M 3.19M 6.06M 405M 41.31M 16.06M 200M 16.04M 15.69M 692M | P/E 2024 |
-3.44x | P/E 2025 | -0.95x |
|---|---|---|---|---|---|
| Enterprise Value | 8.93M 6.19M 5.42M 5M 4.63M 8.79M 588M 59.9M 23.29M 290M 23.25M 22.75M 1B | EV / Sales 2024 |
4.09x | EV / Sales 2025 | 7.81x |
| Free-Float |
78.27% | Yield 2024 * |
-
| Yield 2025 | - |
| 23/05/22 | Acrux : Application for quotation of securities - ACR | PU |
| 14/04/22 | Acrux : Application for quotation of securities - ACR | PU |
| 16/03/22 | Acrux : Application for quotation of securities - ACR | PU |
| 25/02/22 | Acrux : Updated Board Charter | PU |
| 25/02/22 | Acrux : Application for quotation of securities - ACR | PU |
| 1 day | -4.17% | ||
| 1 week | -11.54% | ||
| Current month | -4.17% | ||
| 1 month | -4.17% | ||
| 3 months | +4.55% | ||
| 6 months | -23.33% | ||
| Current year | -23.33% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.02 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.14 | |
| 10 years | 0.01 | 0.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 01/06/2025 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 21/06/2021 |
| Chief Tech/Sci/R&D Officer | - | 15/02/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 01/01/2006 |
Timothy Oldham
BRD | Director/Board Member | - | 01/10/2013 |
Geoff Brooke
BRD | Director/Board Member | 70 | 01/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.17% | -11.54% | -39.47% | -79.09% | 4.27M | ||
| -0.49% | +1.53% | +13.55% | +82.58% | 48.11B | ||
| -1.41% | +5.55% | +70.04% | +116.16% | 37.88B | ||
| -1.39% | -0.16% | -4.06% | +42.16% | 12.47B | ||
| +0.44% | +2.83% | +15.18% | +96.06% | 12B | ||
| +1.82% | +2.76% | +34.19% | +120.25% | 9.03B | ||
| -0.16% | +1.91% | +22.31% | +47.95% | 7.24B | ||
| +0.41% | +2.01% | +55.16% | -3.74% | 7.09B | ||
| -2.81% | +17.66% | -18.38% | +20.93% | 6.54B | ||
| -0.26% | +3.58% | +23.74% | +238.93% | 6.72B | ||
| Average | -0.79% | +2.98% | +17.22% | +68.22% | 14.71B | |
| Weighted average by Cap. | -0.61% | +3.97% | +29.49% | +89.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.09M 3.53M 3.09M 2.85M 2.64M 5.01M 335M 34.14M 13.28M 165M 13.26M 12.97M 572M | 1.19M 825K 722K 666K 617K 1.17M 78.33M 7.98M 3.1M 38.66M 3.1M 3.03M 134M |
| Net income | -5.8M -4.02M -3.52M -3.24M -3.01M -5.71M -382M -38.9M -15.13M -188M -15.1M -14.77M -651M | -5.94M -4.12M -3.61M -3.33M -3.08M -5.85M -391M -39.87M -15.51M -193M -15.48M -15.14M -668M |
| Net Debt | 759K 526K 461K 425K 393K 747K 49.96M 5.09M 1.98M 24.66M 1.98M 1.93M 85.22M | 2.77M 1.92M 1.68M 1.55M 1.44M 2.73M 182M 18.59M 7.23M 90.05M 7.22M 7.06M 311M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | $0.0115 | -4.17% | 81,450 |
| 06/07/26 | $0.0120 | 0.00% | 416,666 |
| 03/07/26 | $0.0120 | 0.00% | 540,342 |
| 02/07/26 | $0.0120 | -7.69% | 3,018,264 |
| 01/07/26 | $0.0130 | +8.33% | 815,493 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions
















